Metformin with Ozanimod Interaction Details
Brand Names Associated with Metformin
- Actoplus Met® (as a combination product containing Metformin, Pioglitazone)
- Avandamet® (as a combination product containing Metformin, Rosiglitazone)
- Fortamet®
- Glucophage®
- Glumetza®
- Invokamet® (as a combination product containing Canagliflozin, Metformin)
- Janumet® (as a combination product containing Metformin, Sitagliptin)
- Jentadueto® (as a combination product containing Linagliptin, Metformin)
- Kazano® (as a combination product containing Alogliptin, Metformin)
- Kombiglyze® XR (as a combination product containing Metformin, Saxagliptin)
- Metaglip® (as a combination product containing Glipizide, Metformin)
- Metformin
- Prandimet® (as a combination product containing Metformin, Repaglinide)
- Qternmet® XR (as a combination product containing Dapagliflozin, Metformin, Saxagliptin), Segluromet® (as a combination product containing Ertugliflozin, Metformin)
- Riomet®
- Synjardy® (as a combination product containing Empagliflozin, Metformin)
- Trijardy® (as a combination product containing Empagliflozin, Linagliptin, Metformin)
- Xigduo® XR (as a combination product containing Dapagliflozin, Metformin)
Brand Names Associated with Ozanimod
- Ozanimod
- Zeposia®

Medical Content Editor Dr. Brian Staiger, PharmD
Last updated
Nov 05, 2023
Interaction Effect
An increased risk of hypoglycemia
Interaction Summary
The glucose lowering effects of hypoglycemic agents may be increased with concomitant use of some MAOIs. MAOIs may cause hyperinsulinemia in patients with type 2 diabetes who have a retained capacity to secrete insulin . Closely monitor blood glucose levels when an MAOI is added or discontinued in a patient receiving a hypoglycemic agent. Lower doses of insulin or oral hypoglycemic agents may be necessary or discontinuation of one of the interacting agents may be required .
Severity
Moderate
Onset
Rapid
Evidence
Probable
How To Manage Interaction
The glucose lowering effects of hypoglycemic agents may be increased with concomitant use of some MAOIs, increasing the susceptibility to or intensity of hypoglycemia. Closely monitor blood glucose levels when an MAOI is added or discontinued in a patient receiving hypoglycemics. Lower doses of insulin or oral hypoglycemic agents may be necessary , or discontinuation of one of the interacting agents may be required .
Mechanism Of Interaction
Unknown
Literature Reports
A) MAOI drugs may enhance the hypoglycemic effects of hypoglycemic drugs. The proposed mechanism was interference of MAOI drugs with homeostatic adrenergic response to hypoglycemia , but this mechanism was not confirmed . MAOIs appear to cause hyperinsulinemia .
B) Treatment with selegiline (a specific MAO-B inhibitor) produced profound hypoglycemia in a 70-year old man with Parkinson's disease. The hypoglycemia was accompanied by hyperinsulinemia and persisted for one week after selegiline was discontinued .
Metformin Overview
-
Metformin is used alone or with other medications, including insulin, to treat type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in the blood). Metformin is in a class of drugs called biguanides. Metformin helps to control the amount of glucose (sugar) in your blood. It decreases the amount of glucose you absorb from your food and the amount of glucose made by your liver. Metformin also increases your body's response to insulin, a natural substance that controls the amount of glucose in the blood. Metformin is not used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood).
-
Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Taking medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.
Ozanimod Overview
-
Ozanimod is used to treat adults with relapsing forms of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control) including clinically isolated syndrome (CIS; nerve symptom episodes that last at least 24 hours), relapsing-remitting forms (course of disease where symptoms flare up from time to time), or secondary progressive forms (course of disease where relapses occur more often). It is also used to treat ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum) in adults. Ozanimod is in a class of medications called sphingosine l-phosphate receptor modulators. It works by decreasing the action of immune cells that may cause nerve damage.
Return To Our Drug Interaction Homepage
Feedback, Question Or Comment About This Information?
Ask Dr. Brian Staiger, PharmD, our medical editor, directly! He's always more than happy to assist.
Definitions
Severity Categories
Contraindicated
These drugs, generally, should not be used together simultaneously due to the high risk of severe adverse effects. Combining these medications can lead to dangerous health outcomes and should be strictly avoided unless otherwise instructed by your provider.
Major
This interaction could result in very serious and potentially life-threatening consequences. If you are taking this drug combination, it is very important to be under close medical supervision to minimize severe side effects and ensure your safety. It may be necessary to change a medication or dosage to prevent harm.
Moderate
This interaction has the potential to worsen your medical condition or alter the effectiveness of your treatment. It's important that you are monitored closely and you potentially may need to make adjustments in your treatment plan or drug dosage to maintain optimal health.
Minor
While this interaction is unlikely to cause significant problems, it could intensify side effects or reduce the effectiveness of one or both medications. Monitoring for changes in symptoms and your condition is recommended, and adjustments may be made if needed to manage any increased or more pronounced side effects.
Onset
Rapid: Onset of drug interaction typically occurs within 24 hours of co-administration.
Delayed: Onset of drug interaction typically occurs more than 24 hours after co-administration.
Evidence
Level of documentation of the interaction.
Established: The interaction is documented and substantiated in peer-reviewed medical literature.
Theoretical: This interaction is not fully supported by current medical evidence or well-documented sources, but it is based on known drug mechanisms, drug effects, and other relevant information.
How To Manage The Interaction
Provides a detailed discussion on how patients and clinicians can approach the identified drug interaction as well as offers guidance on what to expect and strategies to potentially mitigate the effects of the interaction. This may include recommendations on adjusting medication dosages, altering the timing of drug administration, or closely monitoring for specific symptoms.
It's important to note that all medical situations are unique, and management approaches should be tailored to individual circumstances. Patients should always consult their healthcare provider for personalized advice and guidance on managing drug interactions effectively.
Mechanism Of Interaction
The theorized or clinically determined reason (i.e., mechanism) why the drug-drug interaction occurs.
Disclaimer: The information provided on this page is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional regarding your specific circumstances and medical conditions.
Where Does Our Information Come From?
Information for our drug interactions is compiled from several drug compendia, including:
The prescribing information for each drug, as published on DailyMED, is also used.
Individual drug-drug interaction detail pages contain references specific to that interaction. You can click on the reference number within brackets '[]' to see what reference was utilized.
The information posted is fact-checked by HelloPharmacist clinicians and reviewed quarterly.